Correlation Between PDS Biotechnology and Axsome Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Axsome Therapeutics, you can compare the effects of market volatilities on PDS Biotechnology and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Axsome Therapeutics.

Diversification Opportunities for PDS Biotechnology and Axsome Therapeutics

PDSAxsomeDiversified AwayPDSAxsomeDiversified Away100%
-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between PDS and Axsome is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Axsome Therapeutics go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Axsome Therapeutics

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Axsome Therapeutics. In addition to that, PDS Biotechnology is 1.18 times more volatile than Axsome Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.3 per unit of volatility. If you would invest  10,311  in Axsome Therapeutics on November 25, 2024 and sell it today you would earn a total of  3,464  from holding Axsome Therapeutics or generate 33.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  Axsome Therapeutics

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -40-20020
JavaScript chart by amCharts 3.21.15PDSB AXSM
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb1.41.61.822.22.4
Axsome Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Axsome Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Axsome Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb8090100110120130140

PDS Biotechnology and Axsome Therapeutics Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-9.33-6.99-4.64-2.30.02.024.116.28.2910.38 0.0120.0140.0160.0180.0200.0220.024
JavaScript chart by amCharts 3.21.15PDSB AXSM
       Returns  

Pair Trading with PDS Biotechnology and Axsome Therapeutics

The main advantage of trading using opposite PDS Biotechnology and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.
The idea behind PDS Biotechnology Corp and Axsome Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance